Clinical trials
Suspended Major Depressive Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 1 |
| Massachusetts General Hospital | 1 |
| Medical University of South Carolina | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| New York State Psychiatric Institute | 1 |
| ProgenaBiome | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 7 |
| Acne Vulgaris | 1 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Anxiety Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
| Autism Spectrum Disorder | 1 |
| Autistic Disorder | 1 |
| Bipolar Disorder | 1 |
| Bipolar and Related Disorders | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.